×
Please click
here
if you are not redirected within a few seconds.
All
News
Videos
Images
Maps
Shopping
Books
Search tools
Recent
Recent
Past hour
Past 24 hours
Past week
Past month
Past year
Archives
Sorted by relevance
Sorted by relevance
Sorted by date
Is Amarin (AMRN) Stock Outpacing Its Medical Peers This Year?
Yahoo Finance
Here is how Amarin (AMRN) and ANI Pharmaceuticals (ANIP) have performed compared to their sector so far this year.
2 days ago
Amarin Plc (AMRN) Q1 2024 Earnings Call Transcript
The Motley Fool
Amarin Plc (AMRN -8.86%) Q1 2024 Earnings Call May 01, 2024, 8:00 a.m. ET. Contents: Prepared Remarks; Questions and Answers...
4 days ago
Court Tosses Amarin Fair Trade Complaint Against Omega-3 Imports
Pink Sheet
Majority opinion by Federal Circuit upheld International Trade Commission's decision and denied as moot Amarin's petition for order to compel a judicial or...
3 days ago
Amarin Corp. (AMRN) Tops Q1 EPS by 2c, offers outlook
StreetInsider.com
Amarin Corp. (NASDAQ: AMRN) reported Q1 EPS of ($0.01), $0.02 better than the analyst estimate of ($0.03). Revenue for the quarter came in...
4 days ago
Amarin's Leadership: Who's at the Helm?
AOL.com
In this video, Motley Fool health-care analyst Max Macaluso takes a closer look at the leadership of Amarin (NAS: AMRN) , maker of the triglyceride-lowering...
2 days ago
Teva Hits Amarin With Antitrust Lawsuit Over Generic Competition
Bloomberg Law News
Teva Pharmaceuticals is challenging Amarin Pharma Inc., alleging it entered exclusive agreements with active pharmaceutical ingredient...
1 month ago
AMRN Stock Earnings: Amarin Corp Beats EPS, Misses Revenue for Q1 2024
InvestorPlace
AMRN stock results show that Amarin Corp beat analyst estimates for earnings per share but missed on revenue for the first quarter of 2024.
4 days ago
Teva, like Hikma, accuses Amarin of hoarding Vascepa ingredient
Fierce Pharma
In a new lawsuit, Teva flagged Amarin's “anti-competitive conduct to prevent and delay generic competition” to Vascepa—a fish-oil-derived...
1 month ago
Amarin reports Q1 EPS (1c), consensus (3c) - TipRanks.com
Tipranks
Reports Q1 revenue $55.156M, consensus $57.04M. “Our team continued to make progress across aspects of our business in the first quarter of...
4 days ago
Fed. Circ. Seems Ready To Revive Amarin's Skinny Label Suit
Law360
A Federal Circuit panel seemed wary Tuesday of a Delaware federal judge's decision to throw out Amarin Pharma Inc.'s infringement suit over...
1 month ago